Back to DE D. E. Shaw & Co., Inc.
RARE29 quarters
Position history for DED. E. Shaw & Co., Inc.'s holdings in ULTRAGENYX PHARMACEUTICAL IN
D. E. Shaw & Co., Inc. holds 1.3M shares of RARE (ULTRAGENYX PHARMACEUTICAL IN), worth $26.4M as of 2026-Q1. The position was increased (+265.8% shares). RARE represents 0.0% of D. E. Shaw & Co., Inc.'s portfolio.
Current Value
$26.4M
Current Shares
1.3M
Total Value Change
+$12.4M
Total Shares Change
+939,184
Quarter-by-Quarter History
Other major holders of RARE: Capital Research Global Investors, Capital International Investors, FEDERATED HERMES, INC.